Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York State Psychiatric Institute |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000271 |
The purpose of this study is to measure the effect of desipramine in cocaine abusers selected for major depression or dysthymia.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders Substance-Related Disorders |
Drug: Desipramine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | New Approaches to Cocaine Abuse Medications (A) |
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, New York | |
Research Foundation for Mental Hygiene | |
New York, New York, United States, 10032 |
Principal Investigator: | Herbert Kleber, M.D. | New York State Psychiatric Institute |
Study ID Numbers: | NIDA-09236-6, P50-09236-6 |
Study First Received: | September 20, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000271 |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Desipramine Cocaine |
Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Disease Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs |
Enzyme Inhibitors Pharmacologic Actions Antidepressive Agents, Tricyclic Pathologic Processes Therapeutic Uses Central Nervous System Agents Antidepressive Agents |